About BAPS - Pramukh Swami Hospital
Clinical Trials at BAPS - Pramukh Swami Hospital
During the past decade, BAPS - Pramukh Swami Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "BAPS - Pramukh Swami Hospital" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Galapagos NV" with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "Janssen Vaccines & Prevention B.V." with 1 trials sponsored and "Kowa Research Institute, Inc."
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "BAPS - Pramukh Swami Hospital"
#1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Molecular Partners AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at BAPS - Pramukh Swami Hospital
According to Clinical.Site data, the most researched conditions in "BAPS - Pramukh Swami Hospital" are
"Cardiovascular Disease" (2 trials), "Crohn's Disease" (2 trials), "Influenza A" (2 trials), "Anemia" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "BAPS - Pramukh Swami Hospital" in a lesser frequency.
Clinical Trials Intervention Types at BAPS - Pramukh Swami Hospital
Most popular intervention types in "BAPS - Pramukh Swami Hospital" are "Drug" (11 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Filgotinib" (2 trials), "Pimodivir 600 mg" (2 trials), "SOC Treatment" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at BAPS - Pramukh Swami Hospital
The vast majority of trials in "BAPS - Pramukh Swami Hospital" are
11 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at BAPS - Pramukh Swami Hospital
Currently, there are NaN active trials in "BAPS - Pramukh Swami Hospital".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in BAPS - Pramukh Swami Hospital,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in BAPS - Pramukh Swami Hospital, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".